Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solvents-Reference-Cited by-同舟云学术

Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solvents

Published:2007-02 Issue: Volume:1133 Page:186-192
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Rosenberg Gary A.,Estrada Eduardo Y.,Mobashery Shahriar

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference29 articles.

1. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues;Andersson;Neuroscience,1992

2. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model;Bardutzky;J. Cereb. Blood Flow Metab.,2005

3. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis;Brundula;Brain,2002

4. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease;Chen;Nat. Med.,2000

5. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease;Du;Proc. Natl. Acad. Sci. U. S. A.,2001

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023;MMWR. Recommendations and Reports;2023-11-17

2. Characterization of walking locomotion in aged C57BL/10 mice: a comprehensive gait analysis;2023-04-07

3. Inactivation of microglia dampens blood-brain barrier permeability and loss of dopaminergic neurons in paraquat-lesioned mice;Food and Chemical Toxicology;2023-04

4. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model;International Journal of Molecular Sciences;2022-03-03

5. Oral Minocycline Therapy Improves Symptoms of Myalgic Encephalomyelitis, Especially in the Initial Disease Stage;Internal Medicine;2021-08-15